Stockreport

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 [Yahoo! Finance]

Redhill Biopharma Ltd. - American Depositary Shares  (RDHL) 
US:NASDAQ Investor Relations: ir.redhillbio.com/investor-relations
PDF The patent is supported by previously published pooled data from two Phase 3 studies showing Talicia's efficacy was unaffected by presence of elevated BMI [3] The U.S [Read more]